Literature DB >> 4599422

Controlled trial of depot fluphenazine in out-patient schizophrenics.

R Crawford, A Forrest.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4599422     DOI: 10.1192/bjp.124.4.385

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


× No keyword cloud information.
  7 in total

1.  What's new in the psychopharmacology of schizophrenia.

Authors:  A Rifkin; F Quitkin
Journal:  Bull N Y Acad Med       Date:  1978-10

2.  Treatment compliance and hostility levels of head-injured psychiatric outpatients.

Authors:  I M Salloum; E J Jenkins; B Thompson; D Levi; Y Burnett
Journal:  J Natl Med Assoc       Date:  1990-08       Impact factor: 1.798

3.  Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trials.

Authors:  Taishiro Kishimoto; Alfred Robenzadeh; Claudia Leucht; Stefan Leucht; Koichiro Watanabe; Masaru Mimura; Michael Borenstein; John M Kane; Christoph U Correll
Journal:  Schizophr Bull       Date:  2012-12-17       Impact factor: 9.306

4.  Assessment of drugs in schizophrenia. Diagnosis and patient selection.

Authors:  A D Forrest
Journal:  Br J Clin Pharmacol       Date:  1976-06       Impact factor: 4.335

Review 5.  Long-term depot antipsychotics. A risk-benefit assessment.

Authors:  T R Barnes; D A Curson
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

Review 6.  The problem of non-compliance with drug therapy.

Authors:  L Evans; M Spelman
Journal:  Drugs       Date:  1983-01       Impact factor: 9.546

Review 7.  Depot antipsychotic drugs. Place in therapy.

Authors:  J M Davis; L Matalon; M D Watanabe; L Blake; L ] Metalon L [corrected to Matalon
Journal:  Drugs       Date:  1994-05       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.